Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Closes C$1.6M Private Placement

NEW YORK (GenomeWeb) – GeneNews announced today that it has closed a C$1.6 million ($1.2 million) private placement of stock and warrants.

The placement consisted of about 9.8 million units comprising one common share and one quarter of a warrant for the purchase of one share. A full warrant entitles the holder to buy a share of GeneNews at C$.50 by Aug. 15, 2018.

About 5.1 million of the units were sold to new investors, with 2.5 million units used to retire approximately C$400,000 in debt owed to a major shareholder and company director, GeneNews said. Additionally, 600,000 units were provided in lieu of a C$100,000 cash payment for services rendered by a company director.

GeneNews said it plans to use the proceeds of the private placement — which comes about three month after the firm secured a C$5 million capital commitment from Global Emerging Markets Global Yield Fund — for product commercialization, working capital, and general corporate purposes.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.